Searchable abstracts of presentations at key conferences in endocrinology

ea0056p499 | Diabetes therapy | ECE2018

Metabolic effects of liraglutide in type 2 diabetic patients.

Muros Mariola Mendez , Portillo Cristobal Morales , Hermosilla Antonio Manuel Garrido , Septimo Vianney Magaly Santiago , Perez Antonio Perez , Margalet Victor Sanchez , Brocca Maria Asuncion Martinez

Objectives: Obesity and type 2 diabetes mellitus (DM2) are risk factors for non-alcoholic fatty liver disease (NAFLD). The main objective was to study the incidence of NAFLD using the Hepatic Steatosis Index (HSI) in obese patients with DM2. Secondary objectives were to analyse the effect of liraglutide over HSI, body mass index (BMI) and glycated hemoglobin (HbA1c).Methods: Retrospective observational study of obese type 2 diabetic patients treated with...